MAPK1 and myasthenia gravis: Finally, the top ten hub genes (SRC, STAT3, MAPK1, HSP90AA1, PIK3R1, PIK3CA, RXRA, AKT1, CREBBP, and JAK2) were determined to have a higher therapeutic value for MG against SCI and will be examined subsequently.